![Udayan Guha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Udayan Guha
Hoofd Techniek/Wetenschap/O&O bij
NEXTCURE, INC.
Vermogen: - $ op 30-06-2026
Profiel
Udayan Guha currently works at NextCure, Inc., as Chief Medical Officer from 2025.
Dr. Guha also formerly worked at TCR² Therapeutics, Inc., as Vice President & Head-Clinical Development from 2022 to 2023.
Dr. Guha received his graduate degree from All India Institute of Medical Sciences and doctorate degree from Albert Einstein College of Medicine, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NEXTCURE, INC. -.--% | 22-04-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Udayan Guha
| Bedrijven | Functie | Begin |
|---|---|---|
| NEXTCURE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2023 |
Eerdere bekende functies van Udayan Guha
| Bedrijven | Functie | Einde |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01-04-2023 |
Opleiding van Udayan Guha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
All India Institute of Medical Sciences
 All India Institute of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
